Accendra Health, Inc. ACH
0.71
(0.02)
(2.74%)
as of 25 Sep
- Market cap
- $59.2M
- P/E
- 0.0×
Follow ACH
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(602.33%) | (1,755.61%) | (2,037.64%) | 72.63% | |
| (29.40%) | (30.97%) | (29.76%) | (9.65%) | ||
ROIC |
(10.17%) | 1.31% | 1.19% | 1.58% | |
Return on Tangible Assets |
1,797.67% | 769.45% | 279.71% | 162.35% | |
Average Days of Receivables |
95.70 | 12.67 | 13.94 | 16.56 | |
Free Cash Flow per Share |
(3.60) | (2.93) | (2.03) | (2.75) | |
Free Cash Flow |
(278.42) | (225.15) | (154.99) | (210.90) | |
Capital Expenditures |
(179.44) | (123.36) | (38.19) | (30.49) | |
Piotroski F-Score |
3.00 | 2.00 | 2.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
(5.76%) | (5.44%) | (5.91%) | (15.36%) | |
Accounts Receivable Turnover |
1.79 | 17.58 | 7.94 | 16.73 | |
Accounts Payable Turnover |
(0.35) | 4.07 | 1.67 | 4.11 | |
Inventory Turnover |
(0.44) | 20.74 | 1.99 | 20.49 | |
Average Days of Payables |
(427.82) | 90.11 | 93.21 | 88.18 | |
Days of Inventory on Hand |
(80.40) | 18.45 | 16.23 | 18.33 | |
Tax Rate |
0.07 | 0.01 | (0.07) | (0.04) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
111.03% | 38.65% | 39.04% | 39.14% | |
Share Based Compensation of Revenue |
1.90% | 0.47% | 0.42% | 0.40% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.07 | 0.09 | 0.11 | 0.60 | |
Depreciation/Fixed assets |
2.23 | 0.84 | 1.02 | 1.23 | |
Capex/Depreciation |
(0.31) | (0.57) | (0.16) | (0.12) | |
Revenue per Share |
10.00 | 35.92 | 35.53 | 34.52 | |
Operating CF per Share |
(1.28) | (1.32) | (1.53) | (2.35) | |
Capex per Share |
(2.32) | (1.60) | (0.50) | (0.40) | |
Capex to Sales |
0.23 | 0.04 | 0.01 | 0.01 | |
Net Profit Margin |
(173.35%) | (39.85%) | (39.84%) | (11.41%) |
Columns are period end dates